Search Results - "Asher, A. L."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Murine tumor cells transduced with the gene for tumor necrosis factor- alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors by Asher, AL, Mule, JJ, Kasid, A, Restifo, NP, Salo, JC, Reichert, CM, Jaffe, G, Fendly, B, Kriegler, M, Rosenberg, SA

    Published in The Journal of immunology (1950) (01-05-1991)
    “…Studies of the anti-tumor activity of TNF-alpha in vivo have been hampered by the need to administer systemically toxic doses of the cytokine to obtain a…”
    Get full text
    Journal Article
  2. 2

    Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factor by Karp, SE, Farber, A, Salo, JC, Hwu, P, Jaffe, G, Asher, AL, Shiloni, E, Restifo, NP, Mule, JJ, Rosenberg, SA

    Published in The Journal of immunology (1950) (01-02-1993)
    “…Recent investigations have demonstrated that the in vivo growth of weakly immunogenic murine tumors can be inhibited by genetic manipulations that enable them…”
    Get full text
    Journal Article
  3. 3

    Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response by Restifo, NP, Esquivel, F, Asher, AL, Stotter, H, Barth, RJ, Bennink, JR, Mule, JJ, Yewdell, JW, Rosenberg, SA

    Published in The Journal of immunology (1950) (15-08-1991)
    “…MHC class I-restricted CTL play a central role in the immune response against methylcholanthrene (MCA)-induced sarcomas in mice. We, therefore, hypothesized…”
    Get full text
    Journal Article
  4. 4

    Recombinant human tumor necrosis factor mediates regression of a murine sarcoma in vivo via Lyt-2+ cells by ASHER, A. L, MULE, J. J, ROSENBERG, S. A

    Published in Cancer Immunology Immunotherapy (01-02-1989)
    “…The role of an immune response in recombinant-human-tumor-necrosis-factor(rHTNF)-mediated regression of a weakly immunogenic, MCA-106 sarcoma in vivo was…”
    Get full text
    Journal Article
  5. 5

    Identification of unique murine tumor associated antigens by tumor infiltrating lymphocytes using tumor specific secretion of interferon-gamma and tumor necrosis factor by Barth, Jr, R J, Mulé, J J, Asher, A L, Sanda, M G, Rosenberg, S A

    Published in Journal of immunological methods (05-07-1991)
    “…Stimulation of multiple CD8+ murine tumor infiltrating lymphocyte (TIL) lines and one TIL clone with the tumor of origin of the TIL induced at least three-fold…”
    Get more information
    Journal Article
  6. 6

    Polymeric drug delivery for the treatment of glioblastoma by Wait, Scott D, Prabhu, Roshan S, Burri, Stuart H, Atkins, Tyler G, Asher, Anthony L

    Published in Neuro-oncology (Charlottesville, Va.) (01-03-2015)
    “…Glioblastoma (GBM) remains an almost universally fatal diagnosis. The current therapeutic mainstay consists of maximal safe surgical resection followed by…”
    Get full text
    Journal Article
  7. 7

    Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for tumor necrosis factor

    Published in Human gene therapy (01-02-1992)
    “…When tumor is resected from patients as part of the natural course of their treatment, an attempt will be made to establish a tissue culture line of the tumor…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Patterns of Care for Adults With Newly Diagnosed Malignant Glioma by Chang, Susan M, Parney, Ian F, Huang, Wei, Anderson, Frederick A, Asher, Anthony L, Bernstein, Mark, Lillehei, Kevin O, Brem, Henry, Berger, Mitchel S, Laws, Edward R, Glioma Outcomes Project Investigators, for the

    “…CONTEXT Patients with malignant glioma (grade III or IV) face a poor prognosis, and few evidence-based treatment guidelines are available. There is a dearth of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Safety and feasibility of convection-enhanced delivery of cotara for the treatment of malignant glioma : Initial experience in 51 patients by PATEL, Sunil J, SHAPIRO, William R, LASKE, Douglas W, JENSEN, Randy L, ASHER, Anthony L, WESSELS, Barry W, CARPENTER, Susan P, SHAN, Joseph S, RUTKA, James T, BRUCE, Jeffrey N

    Published in Neurosurgery (01-06-2005)
    “…We report the safety and feasibility of using convection-enhanced delivery to administer Cotara (Peregrine Pharmaceuticals, Inc., Tustin, CA), a novel…”
    Get full text
    Journal Article
  13. 13

    Radiation Therapy by Charkravarti, A., Wang, M., Robins, I., Guha, A., Curren, W., Brachman, D., Schultz, C., Choucair, A., Dolled-Filhart, M., Christiansen, J., Gustavson, M., Molinaro, A., Mischel, P., Lautenschlaeger, T., Dicker, A., Mehta, M., Phillips, C. A., Dhulibala, S., Hallahan, D., Jaboin, J., Cardinale, F. S., Dickey, P., Goodrich, I., Gorelick, J., Sinha, R., Dest, V. M., Chen, C., Olsen, C., Franklin, W., Kleinschmidt-DeMasters, B., Kavanagh, B. D., Lillehei, K., Waziri, A., Damek, D., Gaspar, L. E., Stauder, M. C., Laack, N. N., Link, M. J., Pollock, B. E., Schomberg, P. J., Fraser, J. F., Pannullo, S. C., Moliterno, J., Cobb, W., Stieg, P. E., Vinchon-Petit, S., Jarnet, D., Michalak, S., Lewis, A., Benoit, J.-P., Menei, P., Desmarais, G., Paquette, B., Bujold, R., Mathieu, D., Fortin, D., Cuneo, K. C., Vredenburgh, J. J., Sampson, J. H., Reardon, D. A., Desjardins, A., Peters, K. L., Kirkpatrick, J. P., Patel, P. N., Vyas, R., Suryanarayan, U., Bhavsar, D., Hayhurst, C., Monsalves, E., Van Prooijen, M., Menard, C., Zadeh, G., Chung, C., Burrell, K., Lindsey, P., Burri, S. H., Asher, A. L., Kelly, R. B., Boltes, P., Fraser, R. W., Dilmanian, F. A., Rusek, A., Desnoyers, N. R., Park, J. Y., Dane, B., Dioszegi, I., Hurley, S. D., O'Banion, M. K., Tomasi, D., Wang, R., Meek, A. G., Sleire, L., Wang, J., Heggdal, J., Pedersen, P.-H., Enger, P. O., Clump, D. A., Srinivas, R., Wegner, R. E., Heron, D. E.

    Published in Neuro-oncology (Charlottesville, Va.) (21-10-2010)
    Get full text
    Journal Article
  14. 14
  15. 15

    Transdural metastasis from adenocarcinoma of the prostate mimicking subdural hematoma: Case report by Tomlin, Jeffrey M., Alleyne, Cargill H.

    Published in Surgical neurology (01-11-2002)
    “…BACKGROUND Metastasis of prostatic adenocarcinoma to the nervous system is extremely rare and has been infrequently reported over the last several years. We…”
    Get full text
    Journal Article